• Info
  • Significant Ownership

Significant Ownership of Vivo Opportunity Fund Holdings, L.P.

Signature - Title
/s/ Kevin Dai - Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner
Location
Palo Alto, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Vivo Opportunity Fund Holdings, L.P..

Notify me when Vivo Opportunity Fund Holdings, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Vivo Opportunity Fund Holdings, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SABS SAB Biotherapeutics, Inc. Common Stock, par value $0.0001 per share 10% $54,973,720 25,931,000 Vivo Opportunity Fund Holdings, L.P. 29 Sep 2025
UNCY Unicycive Therapeutics, Inc. Common Stock, $0.001 par value per share 10% $38,405,889 60,961,729 Vivo Opportunity Fund Holdings, L.P. 31 Mar 2025
NERV Minerva Neurosciences, Inc. Common Stock, par value $0.0001 per share 10% $32,476,142 8,591,572 Vivo Opportunity Fund Holdings, L.P. 23 Dec 2025
UNCY Unicycive Therapeutics, Inc. Common Stock, $0.001 par value per share 10% $26,579,323 6,096,175 Vivo Opportunity Fund Holdings, L.P. 30 Sep 2025
IMUX Immunic, Inc. Common Stock, par value $0.0001 per share 10% $17,767,413 29,126,906 Vivo Opportunity Fund Holdings, L.P. 17 Feb 2026
KTTA Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share 10% $12,292,327 17,560,467 Vivo Opportunity Fund Holdings, L.P. 01 Dec 2025
ANTX AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share 8% $3,780,937 2,864,346 Vivo Opportunity Fund Holdings, L.P. 10 Mar 2026
CAMP Camp4 Therapeutics Corp Common Stock, par value $0.0001 per share 7.4% $23,373,365 +$1,788,900 3,856,991 +8.3% Vivo Opportunity Fund Holdings, L.P. 31 Dec 2025
DRUG Bright Minds Biosciences Inc. Common Stock, no par value 6.4% $27,550,801 454,184 Vivo Opportunity Fund Holdings, L.P. 30 Sep 2025
DBVT DBV Technologies S.A. Ordinary shares, nominal value 0.10 euro per share, presented by American Depository Shares 5.7% $281,249,084 -$83,778,284 15,685,950 -23% Vivo Opportunity Fund Holdings, L.P. 12 Jan 2026
CMPX Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share 5.1% $31,485,926 8,995,979 Vivo Opportunity Fund Holdings, L.P. 30 Sep 2025
SLNO Soleno Therapeutics, Inc. Common Stock, $0.001 par value per share 4.2% $152,178,416 -$115,402,258 2,251,160 -43% Vivo Opportunity Fund Holdings, L.P. 30 Sep 2025
RGLS Regulus Therapeutics Inc. Common Stock, $0.001 par value 3.9% $9,086,956 2,696,426 Vivo Opportunity Fund Holdings, L.P. 31 Mar 2025
CMPS COMPASS Pathways plc Ordinary Shares, par value (pound)0.008 per share, represented by American Depositary Shares 3.2% $18,189,851 -$18,189,851 3,174,494 -50% Vivo Opportunity Fund Holdings, L.P. 30 Sep 2025
TERN Terns Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 2.5% $95,817,820 2,700,615 Vivo Opportunity Fund Holdings, L.P. 31 Jan 2025
DCTH Delcath Systems, Inc. Common Stock, $0.01 par value per share 2.2% $9,002,340 750,195 Vivo Opportunity Fund Holdings, L.P. 31 Mar 2025
CDTX Cidara Therapeutics, Inc. Common Stock, $0.0001 par value 0% $0 -$260,297,718 0 -100% Vivo Opportunity Fund Holdings, L.P. 07 Jan 2026

Schedules 13D/G Reported by Vivo Opportunity Fund Holdings, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.